Transit dose contributions to intracavitary and interstitial PDR brachytherapy treatments.
The objective of this study was to determine the magnitude of transit dose contributions to the planned dose in common intracavitary and interstitial brachytherapy treatments delivered using a pulsed dose rate (PDR) remote afterloader. The total transit dose arises from the travel of the radiation source into (entry) and out of (exit) the applicator, and between the dwell positions (inter-dwell). In this paper, we used a well-type ionization chamber to measure the transit dose component for a PDR afterloader and compared the results against measurements for a high dose rate (HDR) afterloader. Our results show that for typical intracavitary and interstitial treatments, the major contribution to transit dose is from the entry+exit source travel, as the inter-dwell component is effectively compensated for (<0.5%) by the afterloader. The transit dose was generally found to be larger for PDR treatments than for HDR treatments, as it is influenced by the source activity, dwell times and number of radiation pulses. The overall increase in the planned dose contributed by the transit dose in a typical intracavitary PDR treatment was estimated to be <2%, but much higher for interstitial treatments. This study shows that the effect of the transit dose on common clinical intracavitary PDR brachytherapy treatments is practically negligible, but requires attention in highly fractionated large volume interstitial treatments.
Department of Medical Physics, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada. geethame@cancerboard.ab.ca
Geetha V
GV
Menon
Marco C
MC
Carlone
Ron S
RS
Sloboda
D000465:Algorithms; D001918:Brachytherapy / Q000295:instrumentation / Q000379:methods*; D019583:Dose Fractionation, Radiation; D011881:Radiotherapy, Computer-Assisted / Q000295:instrumentation / Q000379:methods*; D013997:Time Factors